1-3 of 3
Benjamin Maneglier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Daily Doses of Imatinib By Therapeutic Drug Monitoring Increase the Rates of Molecular Responses in Patients with Chronic Myeloid Leukemia. Final Results of the Randomized OPTIM Imatinib Study

Philippe Rousselot, MD PhD, Hyacinthe Johnson-Ansah, MD, Françoise Huguet, MD, Laurence Legros, MD, Martine Escoffre-Barbe, Martine Gardembas, MD, Pascale Cony-Makhoul, MD, Valérie Coiteux, MD, Laurent Sutton, MD, Wajed Abarah, MD, Camille Pouaty, MD, Jean Michel Pignon, MD, Bachra Choufi, MD, Sorin Visanica, MD, Bénédicte Deau, MD, Stephane Bouchet, MDPhD, Francois Guilhot, MD, Francois-Xavier Mahon, MD PhD Professor, Laure Morisset, Jean-Michel Cayuela, Benjamin Maneglier, MD
Journal: Blood
Blood (2015) 126 (23): 133.
https://doi.org/10.1182/blood.V126.23.133.133
Published: 2015
Journal Articles

Erosion Of The Chronic Myeloid Leukemia Stem Cell Pool By PPARγ Agonists

Stephane Prost, Francis Relouzat, Marc Spenchian, Gérald Massonnet, Jean-Paul Beressi, Els Verhoeyen, Benjamin Maneglier, Sylvie Castaigne, Christine Chomienne, Stany Chretien, Philippe Rousselot, Philippe Leboulch, PhD
Journal: Blood
Blood (2013) 122 (21): 5197.
https://doi.org/10.1182/blood.V122.21.5197.5197
Published: 2013
Journal Articles

Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression

Benoît Malleret, Benjamin Manéglier, Ingrid Karlsson, Pierre Lebon, Michelina Nascimbeni, Leïla Perié, Patricia Brochard, Benoît Delache, Julien Calvo, Thibault Andrieu, Odile Spreux-Varoquaux, Anne Hosmalin, Roger Le Grand, Bruno Vaslin
Journal: Blood
Blood (2008) 112 (12): 4598–4608.
https://doi.org/10.1182/blood-2008-06-162651
Published: 2008
Includes: Supplemental data